Nasdaq Extends Compliance Deadline for Agrifood Pioneer Moolec Science
Luxembourg, Thursday 22 January 2026 The Nasdaq Panel has granted Moolec Science until June 2026 to demonstrate compliance, following a complex restructuring where subsidiary bankruptcies paradoxically boosted equity by over $100 million.
Moolec’s Compliance Extension
Moolec Science S.A., a Luxembourg-based company specialising in molecular farming, received an exception from the Nasdaq Hearings Panel on 22 January 2026 [1]. This exception grants the company until 29 June 2026, to regain compliance with Nasdaq’s minimum stockholders’ equity requirement under Listing Rule 5550(b)(1) [1]. The decision provides Moolec with crucial time to address its financial standing and maintain its Nasdaq listing [1].
Equity Boost from Subsidiary Bankruptcies
The company’s improved equity position follows bankruptcy filings by several subsidiaries at the end of December 2025 [1]. These filings triggered derecognition events under IFRS 10, enabling Moolec to recognise estimated gains [6]. These gains include approximately $91.0 million from the loss of control of Bioceres S.A., $5.2 million from Bioceres LLC, and $4.6 million from Theo I SCSp [1]. Additionally, the recognition of previously eliminated intercompany balances and the conversion of certain preference shares into ordinary shares contributed to the equity increase [1].
Company Strategy and Nasdaq Requirements
Moolec believes that these financial adjustments have already brought it back into compliance with Nasdaq’s equity standards [1]. The company has notified the exchange accordingly and is actively working to maintain its listing [1]. According to Nasdaq, real-time bid and ask information is powered by Nasdaq Basic [3]. However, market data, key data, trending stocks, ETFs, and indexes data are currently unavailable from 19 January 2026 to 22 January 2026 [2].
Broader Market Activity
In related news from the life sciences and technology sectors, 60 Degrees Pharmaceuticals announced a partnership with Runway Health on 14 January 2026 [7]. This partnership aims to provide international travellers with direct access to ARAKODA for malaria prevention [7]. Also, Open World launched Saudi Arabia’s first RWA Tokenization Center of Excellence on 22 January 2026 [7].